Fujian Haixi Pharmaceuticals Co., Ltd. (2637)
Market Closed
12 Aug, 08:00
HKEX HKEX Primary 196. 80
HKD -4
-1.992%
17.61B Market Cap
- P/E Ratio
- Div Yield
52,750 Volume
- Eps
200.8 HKD
Previous Close Want to track 2637 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fujian Haixi Pharmaceuticals Co., Ltd. (2637) Statistics
Valuation metrics
Market Cap 17.61B
Enterprise value 17.08B
Trailing P/E (ttm) 75.86
Forward P/E 69.91
PEG ratio 69.91
Price/Sales (ttm) 30.25
Price/Book (mrq) 9.59
Enterprise Value/Revenue 29.33
Enterprise Value/EBITDA 78.26
Overview
Shares outstanding 78.71M
Float 14.27M
Shares short -
% Held by insiders 0.81%
% Held by institutions 0.06%
Average volume (10 days) 135.13K
Average volume (90 days) 370.49K
Price summary
52-Week low 97.5
52-Week high 302.4
Beta -
50-Day moving average 204.42
200-Day moving average 166.86
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.3%
Operating margin 0.33%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.17%
Income Statement
Revenue (ttm) 582.36M
Revenue per share (ttm) 8.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) 485.56M
EBITDA 218.23M
Net income to common (ttm) 177.03M
Diluted EPS (ttm) 2.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 6.31%
Book value per share (mrq) 23.35
Cash Flow
Cash flow statement 137.94M
Levered free cash flow (LFCF) 177.03M
